Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Bupropion HCL ER

Awarded
SPE2D2-23-D-0002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

National Contract SPE2D2-23-D-0002 is an award between the Defense Logistics Agency Troop Support and Radha Pharmaceuticals Inc. for the supply of Bupropion HCL ER tablets in 150 MG and 300 MG dosages. Effective October 6, 2022, the total award amount is 23,278,523.95 dollars. The contract is managed by the DLA Troop Support Medical Supply Chain FSGB in Philadelphia, Pennsylvania, with performance taking place in Hauppauge, New York. The contract has been extended through multiple modifications to exercise option years, with the most recent action, Modification P00010, extending the period of performance through October 5, 2027. Key administrative updates include the incorporation of the Federal Acquisition Supply Chain Security Act, Drug Supply Chain Security Act labeling requirements for unit-of-use packaging, and various DoD Class Deviations regarding sustainability and equal employment opportunity. Additionally, Modification P00009 incorporated clause 52.222-90 regarding DEI discrimination by federal contractors.

General Info

DLA Troop Support awarded Radha Pharmaceuticals $23.3M for Bupropion HCL ER tablets.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Hauppauge, NY, 11788, USA

Set-Aside

NONE

Award Issued Date

Documents

11

Amendment P00004 to Contract SPE2D2-23-D-0002

PDF, High priority: read this firstamendment
High

Contract Award SPE2D2-23-D-0002 for Bupropion HCL ER

PDF, High priority: read this firstcontract-document
High

Modification P00001 to Contract SPE2D2-23-D-0002

PDF, High priority: read this firstmodification
High

Modification P00003 to Contract SPE2D2-23-D-0002 for Drug Supply Chain Security Act Labeling

PDF, High priority: read this firstmodification
High

Modification P00005 to Contract SPE2D2-23-D-0002

PDF, High priority: read this firstmodification
High

Modification P00006 for Contract SPE2D2-23-D-0002 Option Year 2

PDF, High priority: read this firstmodification
High

Modification P00007 to Contract SPE2D2-23-D-0002

PDF, High priority: read this firstmodification
High

Modification P00008 SPE2D223D0002 Option Year 3

PDF, High priority: read this firstmodification
High

Revised Schedule of Supplies for Bupropion HCL ER Tablets

PDF, High priority: read this firstschedule-of-supplies
High

SPE2D2-23-D-0002 Modification P00009

PDF, High priority: read this firstmodification
High

SPE2D2-23-D-0002 Modification P00010

PDF, High priority: read this firstmodification
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA

Full Description

Show more

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract.


Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).


Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.


Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation.


Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract.


Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.


NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS